Join to View Full Profile
601 Elmwood AveRochester, NY 14642
Phone+1 585-275-5863
Dr. Baumgart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2007 - 2010
Albany Medical CollegeClass of 2007
Certifications & Licensure
NY State Medical License 2014 - 2025
RI State Medical License 2007 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2 Start of enrollment: 2020 May 15
- Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2021 Aug 09
Roles: Contact
- Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial Start of enrollment: 2024 Jul 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Cancer rarely travels alone: Addressing the accumulation of risk and early mortality for older adults with advanced lung cancer.Carolyn J Presley, Megan Baumgart, Balazs Halmos, Efrat Dotan
Journal of Geriatric Oncology. 2024-07-01 - 2 citationsPatient-reported impact of symptoms in lung cancer (PRISM-LC).Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Christine Zizzi
Translational Lung Cancer Research. 2023-07-31 - 4 citationsPortable Medical Orders and End of Life Measures in Acute Myeloid Leukemia and Myelodysplastic Syndromes.Marissa Locastro, Andrea Baran, Jane L. Liesveld, Eric Huselton, Michael W. Becker
Blood Advances. 2021-09-15
Press Mentions
Far from Home for the Holidays, Oral Cancer Survivor Finds Family in Team at Wilmot Cancer InstituteDecember 21st, 2021- Wilmot Cancer Institute in Trials for Drug to Treat Lung Cancer PatientsJune 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
